# INVALVE THERAPEUTICS DEDICATED FUND, LP — Form D

INVALVE THERAPEUTICS DEDICATED FUND, LP of LOUISVILLE, KY, a company, filed a Form D exempt-offering notice with the SEC on 2021-02-08. The offering totals $300K, of which $220K was reported sold. Industry: Investing.

## Offering

- Filed: 2021-02-08
- Form: D
- Accession: 0000892303-21-000004
- Industry: Investing
- Exemptions: 06b
- Total offering: $300K
- Amount sold: $220K
- Remaining: $80K
- Minimum investment: $300
- Investors: 2
- Date of first sale: 2021-01-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-388748

## Issuer

- Name: INVALVE THERAPEUTICS DEDICATED FUND, LP
- CIK: 0001844156
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1902 CAMPUS PLACE, SUITE 12, LOUISVILLE, KY, 40299
- Phone: 502-216-0507

## Officers, directors & promoters (1)

| Name | Role | Location |
| --- | --- | --- |
| William Spence | Executive Officer | Louisville, KY |

## More

- [CIK 1844156 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1844156&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0000892303-21-000004.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.